These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias. Makkar KM; Sanoski CA; Spinler SA Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795 [TBL] [Abstract][Full Text] [Related]
4. [The effect of inhibition of renin-angiotensin system on cardioversion success and recurrences of atrial fibrillation]. Doğan A; Akçay S Anadolu Kardiyol Derg; 2009 Dec; 9(6):505-11. PubMed ID: 19965325 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme. Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834 [TBL] [Abstract][Full Text] [Related]
6. Left atrial pacemaker dominance after catheter ablation of atrial fibrillation. Sanders P; Scavée C; Jaïs P; Haïssaguerre M J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1324-7. PubMed ID: 15574186 [TBL] [Abstract][Full Text] [Related]
7. Randomized evaluation of right atrial ablation after left atrial ablation of complex fractionated atrial electrograms for long-lasting persistent atrial fibrillation. Oral H; Chugh A; Good E; Crawford T; Sarrazin JF; Kuhne M; Chalfoun N; Wells D; Boonyapisit W; Gadeela N; Sankaran S; Kfahagi A; Jongnarangsin K; Pelosi F; Bogun F; Morady F Circ Arrhythm Electrophysiol; 2008 Apr; 1(1):6-13. PubMed ID: 19808388 [TBL] [Abstract][Full Text] [Related]
8. [Atrial remodeling and anti-remodeling therapy in atrial fibrillation]. Neumann T; Hölschermann H Dtsch Med Wochenschr; 2006 Apr; 131(16):884-7. PubMed ID: 16625482 [No Abstract] [Full Text] [Related]
10. Mechanisms of atrial remodeling and clinical relevance. Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955 [TBL] [Abstract][Full Text] [Related]
11. [Innovative therapeutic approach to atrial fibrillation: AT1-receptor blocker]. Goette A Dtsch Med Wochenschr; 2006 Aug; 131(34-35 Suppl 4):S103-7. PubMed ID: 16921445 [No Abstract] [Full Text] [Related]
12. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans. Rostock T; Steven D; Lutomsky B; Servatius H; Drewitz I; Klemm H; Müllerleile K; Ventura R; Meinertz T; Willems S J Am Coll Cardiol; 2008 Jun; 51(22):2153-60. PubMed ID: 18510963 [TBL] [Abstract][Full Text] [Related]
13. [Atrial fibrillation in patients with heart failure. Pathophysiological concepts and therapeutic options]. Boldt LH; Rolf S; Dietz R; Haverkamp W Dtsch Med Wochenschr; 2008 Nov; 133(45):2349-54. PubMed ID: 18958832 [No Abstract] [Full Text] [Related]
17. Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation. Choi JI; Park SM; Park JS; Hong SJ; Pak HN; Lim DS; Kim YH; Shim WJ Circ J; 2008 Dec; 72(12):2051-7. PubMed ID: 18948668 [TBL] [Abstract][Full Text] [Related]